Development of Immunosuppression Regimens to Facilitate Single Donor Islet Transplantation Using Abatacept.
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2016
At a glance
- Drugs Abatacept (Primary)
- Indications Islet cell transplant rejection
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 04 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 May 2012 Planned end date changed from 1 Dec 2010 to 1 Dec 2014 as reported by ClinicalTrials.gov.